Popular Brachytherapy News and Current Events

Popular Brachytherapy News and Current Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 6 | 224 Results
MD Anderson study evaluates need for biopsies during follow-up care in women with early breast cancer
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care. The findings, reported in JAMA Surgery, are the first comprehensive nationwide population-based study regarding the need for breast biopsies performed during follow up after treatment for invasive breast cancer. (2018-01-31)

ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer. The update provides evidence-based recommendations for different patient risk groups, and specifies the most effective forms of brachytherapy. (2017-03-28)

Brachytherapy for cervical cancer does not increase the risk of ureteral stricture
New research presented at the ESTRO 37 conference from two large international trials, shows that intracavitary and interstitial brachytherapy is safe and does not increase the risk of ureteral stricture in cervical cancer patients. Until now, there have been concerns that brachytherapy might increase the risk of this serious, sometimes life-threatening complication, although the treatment itself is associated with better survival. (2018-04-20)

Emory researchers find race and gender gaps in treatment of heart attack
Despite increasing attention to sex and race related disparities in the management of myocardial infarction over the past decade, Emory scientists say there are gender and racial gaps in the U.S. between heart attack therapies white men receive and those offered to women and blacks. (2004-03-09)

ASTRO supports US Nuclear Regulatory Commission final rule
The American Society for Radiation Oncology (ASTRO) applauds the United States Nuclear Regulatory Commission for yesterday's announcement of a final rule that updates the definition of medical events for permanent implant brachytherapy and protects patients' access to this treatment. (2017-08-18)

Radiation rids arteries of re-narrowing for up to five years
People who received radiation in their arteries during angioplasty had a reduced risk of artery renarrowing for up to five years compared to those who got only angioplasty, according to a report in today's Circulation: Journal of the American Heart Association. (2002-05-13)

Single dose of targeted radiotherapy is safe and effective for prostate cancer
A single high dose of radiation that can be delivered directly to the tumor within a few minutes is a safe and effective technique for treating men with low-risk prostate cancer, according to a study presented at the ESTRO 38 conference. (2019-04-28)

Medication does not help prevent ED following radiation therapy for prostate cancer
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA. (2014-04-01)

A gold-standard cancer treatment is in decline, and money may be why
Offering brachytherapy for locally advanced cervical cancer ends up costing hospitals money, potentially explaining its declining use even though it's considered the most effective treatment. (2017-12-12)

Benefit of LDR brachytherapy in patients with early-stage prostate cancer is still unclear
Even eleven years after the first benefit assessment, the evidence base remains inadequate. The hopes to be able to close gaps in knowledge were disappointed when PREFERE failed in 2016 due to a lack of interest. (2018-11-19)

Does single PSA test have effect on prostate cancer detection, death?
A screening program that invited men to a clinic to undergo a single prostate-specific antigen (PSA) test increased detection of low-risk prostate cancer but made no significant difference in prostate cancer deaths after 10 years. (2018-03-06)

Adverse effects, quality of life of treatment vs. no treatment for men with localized prostate cancer
Two studies published by JAMA examine the adverse effects and quality of life as reported by men with localized prostate cancer who chose treatment, observation or active surveillance. (2017-03-21)

Sexual function does not continuously decline after radiation therapy treatments for prostate cancer
Sexual function in prostate cancer patients receiving external beam radiation therapy decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the Jan. 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology. (2010-01-05)

VCU scientists seek to perfect calculations for comparing cervical cancer radiation doses
Research from VCU Massey Cancer Center has found that one of the standard practices for comparing cervical cancer radiation therapy treatments may be misleading, and the use of an alternative mathematical formula could be used to more effectively predict and potentially improve outcomes for patients. (2018-02-06)

PROs indicate brachytherapy alone is the superior treatment
Patient-Reported Outcomes (PROs) from the NRG Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy (EBT+B) to transperineal interstitial permanent brachytherapy (B) alone indicate a significantly different clinician and patient-reported late toxicity profile between arms despite similarities in progression-free survival results. This abstract was presented at the American Society for Radiation Oncology (ASTRO) annual meeting and was awarded as a Best of ASTRO presentation for 2018. (2018-10-21)

Cleveland Clinic leads development of new guidelines for radiation in breast cancer
Cleveland Clinic researcher Chirag Shah, M.D., led the development of updated guidelines for the appropriate and safe utilization of accelerated partial-breast irradiation (APBI). The guidelines are published online in the journal, Brachytherapy. (2017-10-26)

Trial confirms pelvic radiation as standard of care for high-risk endometrial cancer
In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy. (2017-09-25)

Different breast cancer treatment options vary widely in their cost-effectiveness
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values. Some therapies may have fewer complications and be much less expensive than others. Women may be making treatment decisions based on factors other than medical value. (2017-04-10)

Prediction models help determine likelihood of erectile function after treatment for prostate cancer
The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function two years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the Sept. 21 issue of JAMA. (2011-09-20)

Single dose of brachytherapy may be an effective treatment for localized prostate cancer
Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray (Gy) treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer. (2017-03-01)

Coronary aneurysms are independent predictor of mortality, should be aggressively monitored
The results of a study presented today at the American College of Cardiology's 53rd Scientific Sessions in New Orleans concludes that coronary aneurysms -- regardless of size -- are associated with a increased risk of death over a five year period and should be aggressively monitored. (2004-03-08)

Radiation therapy technique reduces length of prostate cancer treatment
Breihan Bridgewater suffers from emphysema. He sleeps on his side because when he lays flat on his back it feels like there's a boulder resting on his chest. (2007-09-20)

Radiation device in the breast reduces complications for early stage breast cancer patients
A new study shows that the SAVI applicator, a small, expandable device inserted inside the breast to deliver partial breast irradiation, carries a low infection risk, a potential complication of such devices. (2009-04-23)

Combining hormones with external, internal radiation helps high risk prostate cancer patients
Prostate cancer patients with high risk cancers who are treated with both internal and external radiation and hormone treatment have a better chance of beating the disease than patients treated with radiation alone, according to a new study published in the January 1, 2005, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. (2004-12-29)

How prostate cancer therapies compare by cost and effectiveness
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at the University of California, San Francisco. (2013-01-04)

Type of treatment for prostate cancer affects quality of life
Quality of life after prostate cancer treatment varies by the type of treatment patients receive, a new study reveals. (2017-04-20)

Media can register now for ESTRO 36 - Europe's largest congress on radiation oncology
Journalists can register now for ESTRO 36 - Europe's largest congress on radiation oncology, organised by the European Society for Radiotherapy and Oncology (ESTRO). (2017-03-01)

Queen's University Belfast leads study to transform prostate cancer treatment
Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation in how prostate cancer is diagnosed and treated. (2017-10-23)

Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy had significantly reduced mortality rates. (2012-01-25)

Addition of EBT to brachytherapy does not produce superior PFS results
NRG Oncology researchers reported that adding external radiation therapy to standard brachytherapy did not improve progression-free survival for men with intermediate-risk prostate cancer. (2016-10-03)

$10M grant to VCU to develop new cancer treatments
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments. (2007-05-08)

Mastectomy and reconstruction has higher complication rates, costs than lumpectomy and radiation
Among the various guideline-concordant local therapy options available for women with early-stage breast cancer in the United States, mastectomy plus reconstruction had the highest complication rates and complication-related costs for both younger women with private insurance and older women on Medicare, and it was the most expensive option for younger women, according to data presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12. (2015-12-10)

UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period. (2011-02-15)

Radioactive bone cement found to be safer in treating spinal tumors
A radioactive bone cement that's injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a study led by University of California, Irvine researchers. (2021-02-16)

An invitation to ESTRO 35
The ESTRO 35 congress will feature new research results in clinical radiation oncology, radiobiology, physics, technology, patient care, radiation therapy and brachytherapy, presented by top doctors, scientists and radiation therapists from all over the world, working together for the benefit of cancer patients. The congress is expected to attract 5,000 delegates from more than 80 countries. (2016-01-26)

Black men less likely to be treated for aggressive prostate cancer, UMHS study finds
Black men with the most aggressive form of prostate cancer are less likely than white men to receive surgery or radiation therapy, according to a new study by University of Michigan Health System researchers. (2004-03-29)

Outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer
Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants. (2020-10-28)

Task force develops new radiation guidelines for brachytherapy
Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of medical physics in the department of radiation oncology at Thomas Jefferson University. (2009-11-02)

Less than half of cervical cancer patients receive standard-of-care treatment
University of Colorado Cancer Center study shows that only 44 percent of patients in a large, national sample received all three components of standard-of-care treatment for cervical cancer, most often lacking brachytherapy. (2016-10-31)

Giving a single, high dose of radiation directly to the site of a prostate tumor is safe
Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumor results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses. The research is presented at the 36th annual congress of the European SocieTy for Radiotherapy & Oncology (ESTRO 36). (2017-05-06)

Page 1 of 6 | 224 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.